Region Midtjylland — Sponsor Intelligence | 59 EU Trials

Filter these 59 trials by condition, phase, country and more.

Open in Search →

59 Registered trials

36 Recruiting

15 Completed trials

4 Countries active

90 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase III/IV

Phase IV

Phase III: 11 Phase II/III: 1 Phase II: 8 Phase I/II: 6 Phase III/IV: 7 Phase IV: 21 Phase I: 2 Phase I (Other): 2 Phase I (FiH): 1

Oversight events:

1 serious breach 1 temporary halt across 2 trials

View oversight register →

100%

15 of 15 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic hepatitis B 2 Turner's syndrome 2 Obesity 1 Implant site infection 1 Non-alcoholic steatohepatitis 1 Glioblastoma multiforme 1 Glioblastoma 1 Malignant glioma 1 Tubulointerstitial nephritis 1 Chronic kidney disease 1 Low anterior resection syndrome 1

Top IMPs

ESTRADIOL 5 SODIUM CHLORIDE 3 FUROSEMIDE 2 IBUPROFEN 2 LIDOCAINE HYDROCHLORIDE 2 PARACETAMOL 2 POMALIDOMIDE 2 PROGESTERONE PH. EUR. 2 SEMAGLUTIDE 2 TAMSULOSIN HYDROCHLORIDE 2 VENETOCLAX 2 ALFACALCIDOL 1

All trials — page 2

59 total

HYPOCARE TREAT Recruiting

2024-516000-41-01 Phase IV 1 country
Comparing the Efficacy and Safety of Aspirin Alone versus Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (… Recruiting

2024-517229-18-00 Phase III/IV 1 country
Bisphosphonate vs. Placebo Prior to Parathyroidectomy in Primary Hyperparathyroidisme: A Randomized, blinded Placebo-controlled Trial Recruiting

2024-520073-13-00 Phase III/IV 1 country ZOLEDRONIC ACID
Pomalidomide as an immune-enhancing agent for the control of HIV (PEACH) Recruiting

2024-512797-10-00 Phase I/II 2 countries POMALIDOMIDE
Prednisone treatment in acute interstitial nephritis (PRAISE) Recruiting

2024-520299-86-00 Phase IV 1 country PREDNISOLONE
Dosimetry based PRRT versus standard dose PRRT with Lu-177-DOTATOC in NEN patients- a randomized study; a step towards tailored PRRT. Recruiting

2024-517240-62-00 Phase II 1 country LUTETIUM (177LU) EDOTREOTIDE
Improving diagnostics in cervical dysplasia Recruiting

2024-517151-12-00 Phase IV 1 country ESTRADIOL
An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Recruiting

2023-508444-22-01 Phase I 2 countries
IMpact of Phenylephrine vs. norAdrenaline on systemic hemodynamics and Cerebral Tissue circulation and oxygenation in anesthetized brain tum… Recruiting

2024-515400-40-00 Phase III/IV 1 country
BeDry Recruiting

2023-510187-13-00 Phase III 1 country MIRABEGRON; SOLIFENACIN SUCCINATE
The effect of denosumab on muscle and strength and insulin sensitivity Recruiting

2024-510637-18-00 Phase IV 1 country
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle… Recruiting

2023-504616-15-02 Phase III 1 country ESTRADIOL; PROGESTERONE PH. EUR.
Haemodynamic Effects of Dobutamine in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) Recruiting

2023-508298-10-00 Phase II 1 country DOBUTAMINE; SODIUM CHLORIDE
EDULOX 2- Patientundervisning og medicinsk behandling (duloxetin/aktiv placebo) til patienter med svær funktionel lidelse: et randomiseret, … Recruiting

2024-514264-42-00 Phase IV 1 country DULOXETINE
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren Contracture Affecting the Metacarpophalangeal Joint. A Randomized … Recruiting

2022-501549-57-00 Phase III 1 country ANHYDROUS LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE
Administration of the BCL-2 antagonist, venetoclax, to promote apoptosis of HIV-infected cells and reduce the size of the HIV reservoir: An … Recruiting

2024-518873-32-00 Phase I/II 1 country VENETOCLAX
Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathy Recruiting

2024-515346-17-00 Phase IV 1 country
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome Recruiting

2024-518001-18-00 Phase IV 1 country ESTRADIOL
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women with Turner Syndrome Recruiting

2024-518557-42-00 Phase IV 1 country ESTRADIOL
OPTIMISE Recruiting

2023-509814-12-00 Phase II 3 countries
Investigation of cardiac metabolism in patients with heart failure using hyperpolarized MRI Recruiting

2024-515414-40-00 Phase I/II 1 country PYRUVIC ACID
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention Ended

2024-514868-11-00 Phase II/III 1 country DAPAGLIFLOZIN
StayDry Ended

2023-510280-35-00 Phase IV 1 country
MASTER Ended

2024-515404-39-00 Phase III 1 country ATORVASTATIN

Showing 25–48 of 59 trials

← All sponsors A–Z